These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20497659)

  • 21. [Corticosteroid therapy for the prophylaxis of bronchopulmonary dysplasia in kids with very low body weight].
    Tsvetkova S; Chernookova V
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():21-3. PubMed ID: 19708190
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances and issues in bronchopulmonary dysplasia.
    Zimmerman JJ; Farrell PM
    Curr Probl Pediatr; 1994; 24(5):159-70. PubMed ID: 7915224
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates.
    Mercier JC; Olivier P; Loron G; Fontaine R; Maury L; Baud O
    Semin Fetal Neonatal Med; 2009 Feb; 14(1):28-34. PubMed ID: 18986855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant function and composition in premature infants treated with inhaled nitric oxide.
    Ballard PL; Merrill JD; Truog WE; Godinez RI; Godinez MH; McDevitt TM; Ning Y; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2007 Aug; 120(2):346-53. PubMed ID: 17671061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current status of bronchopulmonary dysplasia].
    Clément A
    Ann Pediatr (Paris); 1988 Sep; 35(7):457-61. PubMed ID: 3052230
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhaled nitric oxide in the premature newborn.
    Kinsella JP; Abman SH
    J Pediatr; 2007 Jul; 151(1):10-5. PubMed ID: 17586183
    [No Abstract]   [Full Text] [Related]  

  • 27. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia.
    Ellsbury DL; Acarregui MJ; McGuinness GA; Eastman DL; Klein JM
    J Perinatol; 2004 Jan; 24(1):36-40. PubMed ID: 14726936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of bronchopulmonary dysplasia.
    Chess PR; D'Angio CT; Pryhuber GS; Maniscalco WM
    Semin Perinatol; 2006 Aug; 30(4):171-8. PubMed ID: 16860156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence.
    Aly H
    Pediatrics; 2007 Apr; 119(4):818-20. PubMed ID: 17403854
    [No Abstract]   [Full Text] [Related]  

  • 30. [Parameters in early prediction of bronchopulmonary dysplasia in preterm infants].
    Somech R; Zangen S; Merlob P
    Harefuah; 1998 Jul; 135(1-2):47-51. PubMed ID: 10909533
    [No Abstract]   [Full Text] [Related]  

  • 31. Definitions and diagnostic criteria for bronchopulmonary dysplasia.
    Bancalari E; Claure N
    Semin Perinatol; 2006 Aug; 30(4):164-70. PubMed ID: 16860155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
    Zupancic JA; Hibbs AM; Palermo L; Truog WE; Cnaan A; Black DM; Ballard PL; Wadlinger SR; Ballard RA;
    Pediatrics; 2009 Nov; 124(5):1325-32. PubMed ID: 19841125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.
    Van Meurs KP; Hintz SR; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Das A; Higgins RD; Stevenson DK
    J Perinatol; 2007 Jun; 27(6):347-52. PubMed ID: 17443204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infants with bronchopulmonary dysplasia suckle with weak pressures to maintain breathing during feeding.
    Mizuno K; Nishida Y; Taki M; Hibino S; Murase M; Sakurai M; Itabashi K
    Pediatrics; 2007 Oct; 120(4):e1035-42. PubMed ID: 17893188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at <32 weeks' gestation.
    Padula MA; Grover TR; Brozanski B; Zaniletti I; Nelin LD; Asselin JM; Durand DJ; Short BL; Pallotto EK; Dykes FD; Reber KM; Evans JR; Murthy K
    J Perinatol; 2013 Nov; 33(11):877-81. PubMed ID: 23828204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
    Ballard PL; Truog WE; Merrill JD; Gow A; Posencheg M; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2008 Mar; 121(3):555-61. PubMed ID: 18310205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH
    N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting risk for bronchopulmonary dysplasia.
    Dunn MS
    Pediatrics; 1990 Nov; 86(5):788-90. PubMed ID: 2235235
    [No Abstract]   [Full Text] [Related]  

  • 39. NO for preterm infants at risk of bronchopulmonary dysplasia.
    Sosenko IR; Bancalari E
    Lancet; 2010 Jul; 376(9738):308-10. PubMed ID: 20655103
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advances in bronchopulmonary dysplasia].
    Liao LJ; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):231-3. PubMed ID: 15144727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.